NYSE:GMED Globus Medical (GMED) Stock Price, News & Analysis $83.58 +0.26 (+0.31%) (As of 11/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Globus Medical Stock (NYSE:GMED) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Globus Medical alerts:Sign Up Key Stats Today's Range$82.35▼$83.9150-Day Range$69.33▼$83.5852-Week Range$44.02▼$84.87Volume1.04 million shsAverage Volume1.06 million shsMarket Capitalization$11.38 billionP/E Ratio124.75Dividend YieldN/APrice Target$88.18Consensus RatingModerate Buy Company OverviewGlobus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.Read More… I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Globus Medical Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks90th Percentile Overall ScoreGMED MarketRank™: Globus Medical scored higher than 90% of companies evaluated by MarketBeat, and ranked 85th out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingGlobus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.58, and is based on 8 buy ratings, 3 hold ratings, and 1 sell rating.Amount of Analyst CoverageGlobus Medical has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Globus Medical's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth15.10% Earnings GrowthEarnings for Globus Medical are expected to grow by 15.10% in the coming year, from $2.98 to $3.43 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Globus Medical is 124.75, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 123.44.Price to Earnings Ratio vs. SectorThe P/E ratio of Globus Medical is 124.75, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 83.57.Price to Earnings Growth RatioGlobus Medical has a PEG Ratio of 1.99. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGlobus Medical has a P/B Ratio of 2.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Globus Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.10% of the outstanding shares of Globus Medical have been sold short.Short Interest Ratio / Days to CoverGlobus Medical has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Globus Medical has recently increased by 0.70%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGlobus Medical does not currently pay a dividend.Dividend GrowthGlobus Medical does not have a long track record of dividend growth. Sustainability and ESG4.1 / 5Environmental Score-0.93 Percentage of Shares Shorted2.10% of the outstanding shares of Globus Medical have been sold short.Short Interest Ratio / Days to CoverGlobus Medical has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Globus Medical has recently increased by 0.70%, indicating that investor sentiment is decreasing. News and Social Media4.0 / 5News Sentiment1.18 News SentimentGlobus Medical has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Globus Medical this week, compared to 7 articles on an average week.Search Interest4 people have searched for GMED on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows10 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Globus Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,512,850.00 in company stock.Percentage Held by Insiders18.54% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Globus Medical's insider trading history. Receive GMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address GMED Stock News HeadlinesGlobus Medical, Inc. (NYSE:GMED) SVP Sells $405,050.00 in StockNovember 9, 2024 | insidertrades.comGlobus Medical’s Strong Q3 Performance and Conservative Outlook Justify Hold Rating Amid Merger ChallengesNovember 15, 2024 | markets.businessinsider.comBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.November 21, 2024 | Brownstone Research (Ad)Some May Be Optimistic About Globus Medical's (NYSE:GMED) EarningsNovember 13, 2024 | finance.yahoo.comGlobus Medical price target raised to $83 from $74 at Morgan StanleyNovember 12, 2024 | markets.businessinsider.comGlobus Medical price target raised to $87 from $78 at BTIGNovember 8, 2024 | markets.businessinsider.comGlobus Medical rises 8% on raised 2024 guidanceNovember 7, 2024 | msn.comTruist Financial Sticks to Its Hold Rating for Globus Medical (GMED)November 6, 2024 | markets.businessinsider.comSee More Headlines GMED Stock Analysis - Frequently Asked Questions How have GMED shares performed this year? Globus Medical's stock was trading at $53.29 at the beginning of 2024. Since then, GMED shares have increased by 56.8% and is now trading at $83.58. View the best growth stocks for 2024 here. How were Globus Medical's earnings last quarter? Globus Medical, Inc. (NYSE:GMED) issued its earnings results on Tuesday, November, 5th. The medical device company reported $0.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.65 by $0.18. The firm's revenue was up 63.1% compared to the same quarter last year. Who are Globus Medical's major shareholders? Top institutional investors of Globus Medical include Janus Henderson Group PLC (5.17%), State Street Corp (2.64%), Wellington Management Group LLP (1.90%) and Geode Capital Management LLC (1.39%). Insiders that own company stock include David D Davidar, Ann D Rhoads, Leslie V Norwalk, Keith W Pfeil, James R Tobin, Dan Lemaitre, Daniel T Scavilla and Kelly Huller. View institutional ownership trends. How do I buy shares of Globus Medical? Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Globus Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Globus Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET), Advanced Micro Devices (AMD) and ServiceNow (NOW). Company Calendar Last Earnings11/05/2024Today11/20/2024Fiscal Year End12/31/2024Next Earnings (Estimated)2/18/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:GMED CUSIP37957720 CIK1237831 Webwww.globusmedical.com Phone(610) 930-1800Fax610-930-2042Employees5,000Year FoundedN/APrice Target and Rating Average Stock Price Target$88.18 High Stock Price Target$100.00 Low Stock Price Target$78.00 Potential Upside/Downside+5.5%Consensus RatingModerate Buy Rating Score (0-4)2.58 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)$0.67 Trailing P/E Ratio124.75 Forward P/E Ratio28.05 P/E Growth1.94Net Income$122.87 million Net Margins3.69% Pretax Margin4.88% Return on Equity9.98% Return on Assets7.92% Debt Debt-to-Equity RatioN/A Current Ratio2.51 Quick Ratio1.64 Sales & Book Value Annual Sales$1.57 billion Price / Sales7.26 Cash Flow$3.72 per share Price / Cash Flow22.48 Book Value$29.32 per share Price / Book2.85Miscellaneous Outstanding Shares136,170,000Free Float110,922,000Market Cap$11.38 billion OptionableOptionable Beta1.17 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report This page (NYSE:GMED) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.